Manufacturing and Production
New UK & Ireland general manager for Teva
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, appointment
UAE’s pharmaceutical market projected to grow from $3 billion to $5.7 billion by 2020
October 10, 2016 Manufacturing and Production Abu Dhabi, Dubai, GlobalData, United Arab Emires, growth, medical tourism, pharmaceutical market
Educating pharma
October 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing educated, funding, medical education, transparency
“Incorrect classification” of EpiPen leads to $1 billion bill for US government
October 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, Heather Bresch, Misclassification, Mylan, Price hike, classification, epipen, price, scandal
Teva to sell Allergan’s UK & Ireland generics business for $770m
October 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Teva
Alnylam’s shares plunge by 42% after deaths in clinical trials
October 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alnylam, Shares, clinical trials, deaths, failure, market value, phase III, revusiran
Novartis axes 175 jobs globally in operations reshuffle
October 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Merck’s Keytruda suffers rejection at hands of NICE
October 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSD, Merck, NHS, NICE, keytruda
Roche’s Alecensa receives second FDA Breakthrough Therapy Designation
October 4, 2016 Manufacturing and Production ALK+, Alecensa, FDA, Roche, alk, crizotinib
AstraZeneca’s wins major drug approval by NICE
October 4, 2016 Manufacturing and Production AstraZeneca, Cancer Drug Fund, NHS, Tagrisso
NICE and the CDF: Are they still up to scratch?
October 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer Drugs Fund, NICE
$600m acquisition bolsters Celgene’s blood cancer portfolio
October 3, 2016 Manufacturing and Production, Research and Development Celgene, EngMab, acquisition, lymphoma, multiple myeloma
Meet SHL at 2016 PDA Universe of Pre-filled Syringes & Injection Devices
October 3, 2016 Manufacturing and Production
Professor David Goldstein appointed as chief adviser for AstraZeneca’s genomics initiative
September 30, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pharmafocus: Advances in Oncology available now!
September 30, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, oncology, pharmafocus supplement
